Market Overview:
The global beclomethasone dipropionate market is expected to register a CAGR of 5.5% during the forecast period, 2018-2030. The market growth can be attributed to the increasing prevalence of respiratory diseases, such as asthma and allergic rhinitis. Additionally, rising awareness about the benefits of using beclomethasone dipropionate for treating respiratory diseases is also propelling the growth of this market. Based on type, the global beclomethasone dipropionate market can be segmented into powder and capsule forms. The powder form is expected to dominate the global market during the forecast period owing to its easy availability and low cost as compared to other forms. By application, asthma is estimated to account for a major share of the global beclomethasone dipropionate market in 2018 owing to its high prevalence across all regions studied in this research study.
Product Definition:
Beclomethasone Dipropionate is a synthetic corticosteroid used as an inhaler to prevent and treat asthma. It decreases inflammation in the airways, which allows you to breathe more easily. Beclomethasone Dipropionate is important because it helps control asthma symptoms, including shortness of breath, wheezing, coughing and chest tightness.
Powder:
Powder is a fine, white crystalline powder and is soluble in water. It has the same properties as those of the original drug substance. The dose depends on the product to be administered and its potency. Powder beclomethasone dipropionate has no odor or taste when administered with water or milk; however, it may have an odor after being mixed with other substances such as alcohols, oils or ketones.
Capsule:
A capsule is a small container made up of gelatin, sugar, and phenol. It contains the active ingredient to be administered by injection or oral route. The size and shape of capsules vary according to the dosage form they serve such as solid (pills) or liquid ( syrup). Capsules are widely used for packaging medicines that need to be taken by mouth in order to avoid GI tract irritation.
Application Insights:
The asthma segment dominated the global beclomethasone dipropionate market in 2017 and is expected to witness significant growth over the forecast period. Increasing awareness about this drug as an asthma treatment among both patients and doctors is anticipated to boost demand for this medication. In addition, growing product usage for the management of severe asthma attacks that do not respond to other medications is projected to fuel industry expansion.
Allergic rhinitis was the second largest application segment in 2017 owing to increasing product use for nasal congestion relief from sensitive individuals allergic rhinitis suffers who have not been able double tolerate anti-histamines or are unresponsive towards them.
Regional Analysis:
North America dominated the global beclomethasone dipropionate market in 2017. The presence of major players, favorable reimbursement scenario, and high healthcare expenditure are some of the factors contributing to its largest share. In addition, increasing prevalence of asthma and allergic rhinitis is expected to drive regional growth over the forecast period.
Asia Pacific is anticipated to witness fastest growth during the forecast period owing to rising product demand for various applications such as nasal spray and inhaler from emerging countries such as China and India. Moreover, growing awareness about chronic diseases management through different treatment options will also support regional growth over next eight years.
Growth Factors:
- Increasing incidence of respiratory diseases: The global prevalence of respiratory diseases is increasing due to the changing lifestyle and environmental factors. This is expected to drive the demand for beclomethasone dipropionate in the coming years.
- Growing awareness about asthma and its treatment: There is a growing awareness among people about asthma and its treatment options. This is likely to boost the demand for beclomethasone dipropionate in the near future.
- Rising number of product approvals: The number of product approvals for beclomethasone dipropionate has been rising in recent years, owing to its efficacy in treating respiratory diseases. This is likely to propel the growth of this market in the coming years.
Scope Of The Report
Report Attributes
Report Details
Report Title
Beclomethasone Dipropionate Market Research Report
By Type
Powder, Capsule
By Application
Asthma, Allergic Rhinitis, Others
By Companies
AMRI, Anuh Pharma Ltd, Avik Pharmaceutical, Cipla, Rumit Lifecare, Teva, Halcyon Labs, Qnasl, Parchem, Hovione, AMRI, THYKN (INDIA) INTERNATIONAL, Chiesi
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
240
Number of Tables & Figures
168
Customization Available
Yes, the report can be customized as per your need.
Global Beclomethasone Dipropionate Market Report Segments:
The global Beclomethasone Dipropionate market is segmented on the basis of:
Types
Powder, Capsule
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Asthma, Allergic Rhinitis, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- AMRI
- Anuh Pharma Ltd
- Avik Pharmaceutical
- Cipla
- Rumit Lifecare
- Teva
- Halcyon Labs
- Qnasl
- Parchem
- Hovione
- AMRI
- THYKN (INDIA) INTERNATIONAL
- Chiesi
Highlights of The Beclomethasone Dipropionate Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Powder
- Capsule
- By Application:
- Asthma
- Allergic Rhinitis
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Beclomethasone Dipropionate Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Beclomethasone dipropionate is a corticosteroid medication that is used to treat various types of inflammation, including asthma. It works by reducing the amount of airway inflammation and mucus production.
Some of the major companies in the beclomethasone dipropionate market are AMRI, Anuh Pharma Ltd, Avik Pharmaceutical, Cipla, Rumit Lifecare, Teva, Halcyon Labs, Qnasl, Parchem, Hovione, AMRI, THYKN (INDIA) INTERNATIONAL, Chiesi.
The beclomethasone dipropionate market is expected to grow at a compound annual growth rate of 5.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Beclomethasone Dipropionate Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Beclomethasone Dipropionate Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Beclomethasone Dipropionate Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Beclomethasone Dipropionate Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Beclomethasone Dipropionate Market Size & Forecast, 2018-2028
4.5.1 Beclomethasone Dipropionate Market Size and Y-o-Y Growth
4.5.2 Beclomethasone Dipropionate Market Absolute $ Opportunity
Chapter 5 Global Beclomethasone Dipropionate Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Beclomethasone Dipropionate Market Size Forecast by Type
5.2.1 Powder
5.2.2 Capsule
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Beclomethasone Dipropionate Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Beclomethasone Dipropionate Market Size Forecast by Applications
6.2.1 Asthma
6.2.2 Allergic Rhinitis
6.2.3 Others
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Beclomethasone Dipropionate Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Beclomethasone Dipropionate Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Beclomethasone Dipropionate Analysis and Forecast
9.1 Introduction
9.2 North America Beclomethasone Dipropionate Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Beclomethasone Dipropionate Market Size Forecast by Type
9.6.1 Powder
9.6.2 Capsule
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Beclomethasone Dipropionate Market Size Forecast by Applications
9.10.1 Asthma
9.10.2 Allergic Rhinitis
9.10.3 Others
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Beclomethasone Dipropionate Analysis and Forecast
10.1 Introduction
10.2 Europe Beclomethasone Dipropionate Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Beclomethasone Dipropionate Market Size Forecast by Type
10.6.1 Powder
10.6.2 Capsule
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Beclomethasone Dipropionate Market Size Forecast by Applications
10.10.1 Asthma
10.10.2 Allergic Rhinitis
10.10.3 Others
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Beclomethasone Dipropionate Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Beclomethasone Dipropionate Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Beclomethasone Dipropionate Market Size Forecast by Type
11.6.1 Powder
11.6.2 Capsule
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Beclomethasone Dipropionate Market Size Forecast by Applications
11.10.1 Asthma
11.10.2 Allergic Rhinitis
11.10.3 Others
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Beclomethasone Dipropionate Analysis and Forecast
12.1 Introduction
12.2 Latin America Beclomethasone Dipropionate Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Beclomethasone Dipropionate Market Size Forecast by Type
12.6.1 Powder
12.6.2 Capsule
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Beclomethasone Dipropionate Market Size Forecast by Applications
12.10.1 Asthma
12.10.2 Allergic Rhinitis
12.10.3 Others
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Beclomethasone Dipropionate Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Beclomethasone Dipropionate Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Beclomethasone Dipropionate Market Size Forecast by Type
13.6.1 Powder
13.6.2 Capsule
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Beclomethasone Dipropionate Market Size Forecast by Applications
13.10.1 Asthma
13.10.2 Allergic Rhinitis
13.10.3 Others
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Beclomethasone Dipropionate Market: Competitive Dashboard
14.2 Global Beclomethasone Dipropionate Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 AMRI
14.3.2 Anuh Pharma Ltd
14.3.3 Avik Pharmaceutical
14.3.4 Cipla
14.3.5 Rumit Lifecare
14.3.6 Teva
14.3.7 Halcyon Labs
14.3.8 Qnasl
14.3.9 Parchem
14.3.10 Hovione
14.3.11 AMRI
14.3.12 THYKN (INDIA) INTERNATIONAL
14.3.13 Chiesi
